Bingli

Bingli Ma has extensive experience in the fields of drug discovery, cancer biology, and immunotherapy, currently serving as a Scientist at Mersana Therapeutics since November 2021. Previous roles include Scientist in Biology at Blueprint Medicines, where work focused on cell-based immune assays and cancer research, and Research Associate II at Sanofi, where responsibilities included bioanalytical assays and laboratory experiment documentation. Bingli's career also includes significant contributions as a Research Investigator at Takeda, focusing on drug metabolism, pharmacokinetics, and drug safety evaluation, along with experience at Wyeth Pharmaceuticals developing molecular biology techniques. Earlier research roles include positions at the College of Pharmacy at Rutgers University and Columbia University, with a foundational background in medical education comprising two Doctor of Medicine degrees from institutions in China.